Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

Br J Haematol. 2012 May;157(4):497-8. doi: 10.1111/j.1365-2141.2012.09029.x. Epub 2012 Feb 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Fatal Outcome
  • Humans
  • Lenalidomide
  • Leukemia, Plasma Cell / drug therapy*
  • Male
  • Middle Aged
  • Neoplasms, Second Primary / drug therapy*
  • Pyrazines / administration & dosage
  • Recurrence
  • Remission Induction
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives

Substances

  • Boronic Acids
  • Pyrazines
  • Thalidomide
  • Bortezomib
  • Dexamethasone
  • Lenalidomide